Cargando…
Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis
BACKGROUND: Few risk factors have been identified for the development of calcinosis among patients with Juvenile Dermatomyositis, and currently no clinical phenotype has been associated with its development. We analyzed a large database of patients to further elucidate any relationships among patien...
Autores principales: | Orandi, Amir B., Dharnidharka, Vikas R., Al-Hammadi, Noor, Baszis, Kevin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311016/ https://www.ncbi.nlm.nih.gov/pubmed/30594206 http://dx.doi.org/10.1186/s12969-018-0299-9 |
Ejemplares similares
-
Assessment, classification and treatment of calcinosis as a complication of juvenile dermatomyositis: a survey of pediatric rheumatologists by the childhood arthritis and rheumatology research alliance (CARRA)
por: Orandi, A. B., et al.
Publicado: (2017) -
Favorable outcomes with reduced steroid use in juvenile dermatomyositis
por: Orandi, Amir B., et al.
Publicado: (2021) -
Treatment of calcinosis with biphosphonates in juvenile dermatomyositis
por: Bilginer, Y, et al.
Publicado: (2008) -
Calcinosis Universalis in Juvenile Dermatomyositis
por: Chung, Chong Hyuk
Publicado: (2020) -
Calcinosis in juvenile dermatomyositis: Updates on pathogenesis and treatment
por: Pinotti, Caitlan S., et al.
Publicado: (2023)